logo

For the Inventor, By the Inventor

Morristown, NJ, United States of America

Roger A Fujimoto

USPTO Granted Patents = 10

Average Co-Inventor Count = 3.4

ph-index = 3

Forward Citations = 48(Granted Patents)


Location History:

  • Morristown, NJ (US) (2001 - 2007)
  • Winchester, MA (US) (2013 - 2014)

Company Filing History:

goldMedal10 out of 3,923 
 
Novartis Ag
 patents

Years Active: 2001-2014

Loading Chart...
10 patents (USPTO):Explore Patents
1. 8691756 - Macrocycles and their uses (2014-04-08),
2. 8476224 - Macrocycles and their uses (2013-07-02),
3. 7202364 - Certain phenylacetic acids and derivatives (2007-04-10),
4. 7115662 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2006-10-03),
5. 6727281 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2004-04-27),
6. 6451858 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2002-09-17),
7. 6380259 - Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease (2002-04-30),
8. 6310099 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2001-10-30),
9. 6291530 - Aryl-substituted acrylamides with Leukotriene B4 (LTB-4) receptor antagonist activity (2001-09-18),
10. 6291523 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2001-09-18),

Title: Inventor Spotlight: Roger A. Fujimoto

Introduction

Roger A. Fujimoto is a notable inventor based in Morristown, New Jersey, renowned for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, he has established himself as a key figure in the innovation of treatments for bacterial infections and diseases.

Latest Patents

Among Roger's latest patents are two groundbreaking inventions related to macrocycles. The first patent outlines a method for treating bacterial infections by administering a pharmaceutically acceptable amount of a defined macrocycle compound. The second patent focuses on organic compounds that serve to treat, prevent, and ameliorate a variety of diseases. These innovations are reflective of his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Roger A. Fujimoto currently works at Novartis AG, a leading global healthcare company. His role in the organization underscores his expertise in pharmaceutical research and development. Over the years, his inventive contributions have not only garnered patents but also positioned him as a trusted leader in his field.

Collaborations

In his career, Roger has collaborated with talented professionals, including Leslie Wighton McQuire and Benjamin B. Mugrage. These collaborations have led to the development of pioneering solutions that address complex health challenges, further demonstrating the value of teamwork in the innovation process.

Conclusion

Roger A. Fujimoto exemplifies the spirit of innovation through his dedication to creating effective treatments for bacterial infections and other diseases. His combination of skill, teamwork, and visionary thinking continues to make a substantial impact on the pharmaceutical industry, paving the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…